Nicole Concin
Comprehensive Cancer Center Vienna · 326 works · 12,259 citations · h-index 51
Top works
- ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
- ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
- FIGO staging of endometrial cancer: 2023
- ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
- ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
- Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
- Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer
- FIGO staging of endometrial cancer: 2023
- Mineral oil paraffins in human body fat and milk
- ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
- The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study
- Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo
- Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA-IV
- ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma
- Quality indicators for advanced ovarian cancer surgery from the European Society of Gynaecological Oncology (ESGO): 2020 update
- Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial
- ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors
- Plasma Fibrinogen Levels and Prognosis in Patients with Ovarian Cancer: A Multicenter Study
- ESGO–SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers
- Uterine serous carcinoma